Literature DB >> 11684720

Improved objectivity of grading of T(A,1) transitional cell carcinomas of the urinary bladder by quantitative nuclear and proliferation related features.

M G Bol1, J P Baak, P C de Bruin, S Rep, W Marx, S Bos, O Kisman.   

Abstract

AIM: To analyse whether the mean nuclear area of the 10 largest nuclei (MNA-10), the mitotic activity index (MAI), and Ki-67 immunoquantitative features have additional value to discriminate different grades of T(A,1) transitional cell carcinoma (TCC) of the urinary bladder. MATERIALS/
METHODS: One hundred and fifty of 200 consecutive cases (75%) showing interobserver agreement on duplicate blind grade assessment by independent pathologists were studied. Using random numbers, the 150 cases were divided into sets for learning (n = 75) and testing (n = 75). Single and multivariate analyses were applied to discriminate the different grades in the learning set. The multivariate classifier developed in this way was evaluated in the test set (n = 75).
RESULTS: With the MNA-10 alone, using the classification MNA-10 < 80 microm(2) = grade 1, 80 microm(2) < MNA-10 < 130 microm(2) = grade 2, MNA-10 > 130 microm(2) = grade 3, 71% of all 150 cases were correctly classified (69% of grade 1 v grade 2 and 76% of grade 2 v grade 3). With multivariate analysis, the best discriminating features in the learning set (17 grade 1, 30 grade 2, and 28 grade 3) between grades 1 and 2 were MNA-10 and MAI, and between grades 2 and 3 MAI and Ki-67. With these features, 94% of grade 1 v grade 2 and 97% of grade 2 v grade 3 were correctly classified in the learning set (overall, 95% correct, none of the grade 3 cases misclassified). In the test set the classification results were similar. When the three grades were entered at the same time for discrimination, Ki-67 area % and MAI was the best discriminating combination, both in the sets for learning and testing. Overall correct classification results in the sets for learning and testing were slightly lower, but still 94% and 92%. Most importantly, none of the grade 3 cases was misclassified; the classification shifts all occurred between grades 1 and 2.
CONCLUSIONS: The combination of MNA-10, MAI, and Ki-67 gives much better discrimination between grades 1, 2, and 3 in T(A,1) TCC of the urinary bladder than MNA-10 alone. The similarity of the classification results of the learning set and test set are encouraging and this quantitative pathological grading model should be applied in a prospective study.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11684720      PMCID: PMC1731323          DOI: 10.1136/jcp.54.11.854

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  25 in total

1.  Morphometry in human transitional cell bladder cancer. Nuclear area and standard deviation of nuclear area--relation to tumor grade (WHO) and prognosis.

Authors:  P K Lipponen; Y Collan; M J Eskelinen; E Pesonen; M Sotarauta
Journal:  Eur Urol       Date:  1990       Impact factor: 20.096

2.  Benign papilloma or papillary carcinoma of the bladder?

Authors:  L F Greene; K A Hanash; G M Farrow
Journal:  J Urol       Date:  1973-08       Impact factor: 7.450

3.  Comparison of semiautomatic digitizer-tablet and simple point counting performance in morphometry.

Authors:  H Jørgen; G Gundersen; M Boysen; A Reith
Journal:  Virchows Arch B Cell Pathol Incl Mol Pathol       Date:  1981

4.  Mode of presentation of invasive bladder cancer: reassessment of the problem.

Authors:  K W Kaye; P H Lange
Journal:  J Urol       Date:  1982-07       Impact factor: 7.450

5.  Comparison of quantitative and classic prognosticators in urinary bladder carcinoma. A multivariate analysis of DNA flow cytometric, nuclear morphometric and clinicopathological features.

Authors:  C E Blomjous; N W Schipper; W Vos; J P Baak; H J de Voogt; C J Meijer
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1989

Review 6.  The natural history of bladder cancer. Implications for therapy.

Authors:  R Lee; M J Droller
Journal:  Urol Clin North Am       Date:  2000-02       Impact factor: 2.241

7.  A comparative study in morphometric grading of transitional cell carcinoma of the urinary bladder.

Authors:  C E Blomjous; A W Smeulders; J P Baak; W Vos; C M van Galen; C J Meijer
Journal:  Anal Quant Cytol Histol       Date:  1989-12       Impact factor: 0.302

8.  The value of morphometry and DNA flow cytometry in addition to classic prognosticators in superficial urinary bladder carcinoma.

Authors:  E C Blomjous; N W Schipper; J P Baak; W Vos; H J De Voogt; C J Meijer
Journal:  Am J Clin Pathol       Date:  1989-03       Impact factor: 2.493

9.  The significance of lamina propria invasion on the prognosis of patients with bladder tumors.

Authors:  C Anderström; S Johansson; S Nilsson
Journal:  J Urol       Date:  1980-07       Impact factor: 7.450

10.  Comparison of morphometry and DNA flow cytometry with standard prognostic factors in bladder cancer.

Authors:  P K Lipponen; Y Collan; M J Eskelinen; E Pesonen; M Sotarauta; S Nordling
Journal:  Br J Urol       Date:  1990-06
View more
  3 in total

1.  Proliferation markers and DNA content analysis in urinary bladder TaT1 urothelial cell carcinomas: identification of subgroups with low and high stage progression risks.

Authors:  M G W Bol; J P A Baak; B van Diermen; S Buhr-Wildhagen; E A M Janssen; K H Kjellevold; A J Kruse; O Mestad; P Øgreid
Journal:  J Clin Pathol       Date:  2003-06       Impact factor: 3.411

2.  Level of mitoses in non-muscle invasive papillary urothelial carcinomas (pTa and pT1) at initial bladder biopsy is a simple and powerful predictor of clinical outcome: a multi-center study in South Korea.

Authors:  Ji Eun Kwon; Nam Hoon Cho; Yeong-Jin Choi; So Dug Lim; Yong Mee Cho; Sun Young Jun; Sanghui Park; Young A Kim; Sung-Sun Kim; Mi Sun Choe; Jung-Dong Lee; Dae Yong Kang; Jae Y Ro; Hyun-Jung Kim
Journal:  Diagn Pathol       Date:  2017-07-24       Impact factor: 2.644

3.  Role of morphometry and proliferative parameters in grading of urothelial neoplasms.

Authors:  Monika Sangwan; Sunita Singh; Santosh Kumar; Sonia Chabbra; Rajeev Sen; Praveen Rana; Shivani Malik; Sonia Singh; Ramesh Lamba
Journal:  Cent European J Urol       Date:  2015-03-13
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.